HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.

Abstract
Subclinical vitamin C deficiency is widespread in many populations, but its role in both Alzheimer's disease and normal aging is understudied. In the present study, we decreased brain vitamin C in the APPSWE/PSEN1deltaE9 mouse model of Alzheimer's disease by crossing APP/PSEN1(+) bigenic mice with SVCT2(+/-) heterozygous knockout mice, which have lower numbers of the sodium-dependent vitamin C transporter required for neuronal vitamin C transport. SVCT2(+/-) mice performed less well on the rotarod task at both 5 and 12 months of age compared to littermates. SVCT2(+/-) and APP/PSEN1(+) mice and the combination genotype SVCT2(+/-)APP/PSEN1(+) were also impaired on multiple tests of cognitive ability (olfactory memory task, Y-maze alternation, conditioned fear, Morris water maze). In younger mice, both low vitamin C (SVCT2(+/-)) and APP/PSEN1 mutations increased brain cortex oxidative stress (malondialdehyde, protein carbonyls, F2-isoprostanes) and decreased total glutathione compared to wild-type controls. SVCT2(+/-) mice also had increased amounts of both soluble and insoluble Aβ1-42 and a higher Aβ1-42/1-40 ratio. By 14 months of age, oxidative stress levels were similar among groups, but there were more amyloid-β plaque deposits in both hippocampus and cortex of SVCT2(+/-)APP/PSEN1(+) mice compared to APP/PSEN1(+) mice with normal brain vitamin C. These data suggest that even moderate intracellular vitamin C deficiency plays an important role in accelerating amyloid pathogenesis, particularly during early stages of disease development, and that these effects are likely modulated by oxidative stress pathways.
AuthorsShilpy Dixit, Alexandra Bernardo, Jennifer Michelle Walker, John Andrew Kennard, Grace Youngeun Kim, Eric Sean Kessler, Fiona Edith Harrison
JournalACS chemical neuroscience (ACS Chem Neurosci) Vol. 6 Issue 4 Pg. 570-81 (Apr 15 2015) ISSN: 1948-7193 [Electronic] United States
PMID25642732 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • APP protein, human
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • PSEN1 protein, human
  • Peptide Fragments
  • Presenilin-1
  • Slc23a2 protein, mouse
  • Sodium-Coupled Vitamin C Transporters
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
  • Ascorbic Acid
Topics
  • Aging (metabolism, pathology)
  • Alzheimer Disease (metabolism, pathology)
  • Amyloid beta-Peptides (metabolism)
  • Amyloid beta-Protein Precursor (genetics, metabolism)
  • Animals
  • Anxiety (metabolism, pathology)
  • Ascorbic Acid (metabolism)
  • Ascorbic Acid Deficiency (metabolism, pathology, psychology)
  • Brain (metabolism, pathology)
  • Cognition Disorders (metabolism, pathology)
  • Disease Models, Animal
  • Female
  • Learning (physiology)
  • Male
  • Memory (physiology)
  • Mice, Transgenic
  • Motor Activity (physiology)
  • Oxidative Stress (physiology)
  • Peptide Fragments (metabolism)
  • Presenilin-1 (genetics, metabolism)
  • Sodium-Coupled Vitamin C Transporters (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: